UPDATED Aug 25, 2025
Discover large cap Global Pharmaceuticals & Biotech companies from around the world. These Pharmaceuticals & Biotech Companies are organised by Market Cap.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
---|---|---|---|---|---|---|---|---|---|---|
ERF | €66.74 | -0.9% | 28.1% | €11.9b | €63.93 | PE31.1x | E20.5% | 0.9% | ||
6990 | HK$485.60 | 6.5% | 194.8% | HK$107.4b | HK$475.96 | PS67.7x | E67.1% | n/a | ||
ICLR | US$171.75 | -3.8% | -46.8% | US$13.7b | US$216.80 | PE16.8x | E7.7% | n/a | ||
NBIX | US$133.99 | 0.6% | -12.0% | US$13.4b | US$167.87 | PE38.2x | E26.1% | n/a | ||
MEDP | US$466.80 | 0.8% | 21.2% | US$13.0b | US$410.27 | PE31.4x | E8.6% | n/a | ||
REC | €52.30 | 1.1% | 2.4% | €10.8b | €59.62 | PE26.5x | E14.1% | 2.4% | ||
VTRS | US$10.55 | -0.8% | -10.2% | US$12.4b | US$11.43 | PB0.8x | E77.9% | 4.5% | ||
500124 | ₹1,263.35 | 1.5% | -9.3% | ₹1.1t | ₹1,287.88 | PE18.5x | E-1.2% | 0.6% | ||
MANKIND | ₹2,502.00 | 0.4% | 3.1% | ₹1.1t | ₹2,799.65 | PE54.6x | E20.4% | 0.08% | ||
ASND | US$190.37 | -1.9% | 37.4% | US$11.8b | US$252.72 | PS20.2x | E60.5% | n/a | ||
ZYDUSLIFE | ₹987.85 | -0.2% | -11.3% | ₹1.0t | ₹1,006.63 | PE21.7x | E-1.6% | 1.1% | ||
ORNBV | €69.35 | 0.2% | 48.8% | €9.7b | €68.70 | PE25.8x | E13.7% | 2.4% | ||
BMRN | US$58.50 | 1.8% | -35.0% | US$11.2b | US$97.62 | PE17.1x | E17.2% | n/a | ||
IPN | €115.50 | 1.4% | 8.5% | €9.5b | €127.00 | PE21.3x | E11.5% | 1.2% | ||
CAI | US$38.48 | 7.0% | n/a | US$11.1b | US$39.38 | PS20.3x | E80.2% | n/a | ||
603392 | CN¥60.49 | 6.6% | -13.8% | CN¥78.9b | CN¥52.50 | PS44.4x | E174.7% | 0% | ||
RVTY | US$92.14 | 0.8% | -24.7% | US$10.7b | US$116.81 | PE38.4x | E24.3% | 0.3% | ||
QGEN | US$48.90 | -0.6% | 3.3% | US$10.6b | US$52.39 | PE28.4x | E11.9% | 3.1% | ||
SOBI | SEK 290.20 | 3.3% | -6.1% | SEK 101.5b | SEK 341.18 | PE23.2x | E16.0% | n/a | ||
300765 | CN¥53.55 | 9.6% | 123.5% | CN¥75.5b | CN¥54.60 | PS36.2x | E65.1% | 0.04% | ||
MRNA | US$25.35 | -9.8% | -69.0% | US$10.6b | US$45.45 | PS3.2x | E37.3% | n/a | ||
EXEL | US$37.90 | 0.4% | 47.3% | US$10.4b | US$44.74 | PE16.9x | E19.9% | n/a | ||
500257 | ₹1,923.80 | -2.3% | -11.4% | ₹897.2b | ₹2,229.14 | PE23.8x | E4.5% | 0.6% | ||
600196 | CN¥28.55 | 1.3% | 28.0% | CN¥71.8b | CN¥29.24 | PE25.8x | E10.0% | 1.1% |